Add Company
Join Now

Congruence Therapeutics Revenue and Competitors

License our Company Data API

Location

#5755

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Congruence Therapeutics's estimated annual revenue is currently $3.2M per year.(i)
  • Congruence Therapeutics's estimated revenue per employee is $77,500
  • Congruence Therapeutics's total funding is $65M.

Employee Data

  • Congruence Therapeutics has 41 Employees.(i)
  • Congruence Therapeutics grew their employee count by 24% last year.

Congruence Therapeutics's People

NameTitleEmail/Phone
1
Executive Director IP and FounderReveal Email/Phone
2
Co-founder & CEOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Chief Development OfficerReveal Email/Phone
5
EVP Corporate and Business DevelopmentReveal Email/Phone
6
VP, ChemistryReveal Email/Phone
7
EVP Corporate and Business DevelopmentReveal Email/Phone
8
Director ChemistryReveal Email/Phone
9
Associate Director, Medicinal ChemistryReveal Email/Phone
10
Executive Director, Computational Molecular SciencesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.9M1813%$150.5MN/A
#2
$28.4M183-56%N/AN/A
#3
$4.3M288%N/AN/A
#4
$55.6M3591%N/AN/A
#5
$11M7120%N/AN/A
#6
$22.2M143-22%N/AN/A
#7
$4.2M2713%N/AN/A
#8
$2M130%N/AN/A
#9
$295.7M19085%N/AN/A
#10
$2.8M186%N/AN/A
Add Company

What Is Congruence Therapeutics?

Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry. Our ground-breaking discovery engine, Revenir, sees proteins in ways others have been unable to see - in their full dynamic state.

keywords:N/A

$65M

Total Funding

41

Number of Employees

$3.2M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M415%N/A
#2
$4.8M41-7%N/A
#3
$9.5M41-24%N/A
#4
$8M4132%N/A
#5
$8.4M422%N/A